Call for Applications
Bayer G4A Partnerships 2020

Digital health is changing the world. From chronic disease management to prevention,
G4A’s goal is to empower people with the tools and access they need to take control of their
health. G4A does this through partnering with a diverse and vibrant ecosystem of digital health
companies.

The 2020 G4A Partnership Program is now open for applications! This year G4A is seeking to
collaborate with companies that are making an impact in the following areas:

 Cardiometabolic and Renal Diseases – Heart health requires a 360-approach that
encompasses lifestyle behaviors, remote monitoring, biomarker review, risk stratification,
and more

 Oncology – Utilizing targeted therapies and patient performance technologies can
identify patients efficiently and slow disease progression

 Women’s Health – Novel approaches are needed to manage gynecological conditions
such as PCOS and Endometriosis, as well as Menopause, and provide answers to the
unique needs of women’s health

 Pharmacovigilance – The opportunity for innovation in drug safety is huge, specifically
as it relates to adverse event detection

G4A’s 2020 Partnership Program offers two tracks for participation. The Growth Track is
designed for early-stage companies (Seed-Series A) while the Advance Track is for companies
which already have traction in the market with a product or service. Selected partners will
expand their reach and provide valuable solutions in healthcare together with Bayer G4A’s
guidance.

Applications are now open till July 30th. More information about G4A’s
challenges on:  https://www.g4a.health/partnerships

============
Since its launch in 2013, Bayer has supported over 150 digital health companies resulting in
more than 30 direct collaborations. Bayer now operates G4A in more than 13 countries,
developing and promoting collaborative health care technology projects around the world.